Brief: ProQR Announces Third Quarter 2021 Operating And Financial Results

ProQR Therapeutics NV

04/11/2021 13:12

Nov 4 (Reuters) - ProQR Therapeutics NV  PRQR.O :
    * PROQR ANNOUNCES THIRD QUARTER 2021 OPERATING AND FINANCIAL
RESULTS
    * Q3 LOSS PER SHARE EUR 0.22
    * TOP-LINE DATA FROM PIVOTAL PHASE 2/3 ILLUMINATE TRIAL OF
SEPOFARSEN FOR CEP290-MEDIATED LCA10 EXPECTED LATE Q1/EARLY Q2
2022
    * QR-421A PHASE 2/3 SIRIUS AND CELESTE TRIALS IN USHER
SYNDROME
AND RETINITIS PIGMENTOSA ON TRACK TO START BY YEAR END 2021
    * Q3 EARNINGS PER SHARE VIEW EUR -0.21 -- REFINITIV IBES
DATA

Source text for Eikon:  ID:nGNX1wZ75w 
Further company coverage:  PRQR.O 

 ((Reuters.Briefs@thomsonreuters.com;))